Cyclin D activates the Rb tumor suppressor by mono-phosphorylation

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The established model of G1 cell cycle progression suggests cyclin D:Cdk4/6 causes Rb tumor suppressor inactivation via multi-phosphorylation.
• This process, termed hypo-phosphorylation, is believed to release E2F transcription factors, but lacks biochemical proof.
• The precise biologically active forms of Rb remain unidentified.

Purpose of the Study:

• To biochemically investigate the phosphorylation status and function of the Rb tumor suppressor in early G1 phase.
• To elucidate the specific roles of different Rb isoforms in cell cycle regulation.
• To challenge and refine the existing model of G1 cell cycle progression.

Main Methods:

• Biochemical assays to determine Rb phosphorylation states.
• Analysis of Rb isoform composition and E1a oncoprotein targeting.
• Investigation of Rb binding patterns with E2F transcription factors.
• Examination of Rb regulation in response to DNA damage and differentiation.

Main Results:

• Rb is exclusively mono-phosphorylated in early G1 phase by cyclin D:Cdk4/6, not multi-phosphorylated.
• Mono-phosphorylated Rb comprises 14 distinct isoforms, all targeted by E1a but with varied E2F binding.
• Cyclin E:Cdk2 mediates quantum hyper-phosphorylation of Rb at the Restriction Point.
• DNA damage response activates cyclin D:Cdk4/6 to produce mono-phosphorylated Rb for global transcription regulation.
• Differentiation utilizes un-phosphorylated Rb.

Conclusions:

• Mono-phosphorylated Rb, generated by cyclin D:Cdk4/6, is the sole active Rb isoform in early G1 phase.
• This finding fundamentally alters the understanding of G1 cell cycle control.
• Rb phosphorylation status dictates its function in cell cycle progression, DNA damage response, and differentiation.